1500KRW
35.10 BKRW
748.53 BKRW
11.82 M
About JWPHARMA(2PB)
Sector
Headquarters
Seoul
Employees (FY)
1.15 K
Website
Founded
1945
ISIN
KR7001062009
FIGI
BBG000BR5H22
JW PHARMACEUTICAL Corp. engages in the development, manufacture, and sale of pharmaceuticals. Its products include analgesics, antipyretics and cold remedy, antidote, antimicrobials, anticancer, antifungal, circulatory system, gastrointestinal, miscellaneous, multivitamins, and anti-anemic agents, contact lens care and ophthalmic agents, topicals, amino acid solutions, flexible intravenous container, intravenous solutions, respiratory, obstetrics, gynecology, and nephrology agents, central nervous system, urology agents, and diabetic agents. The company was founded on August 8, 1945 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 001067 is 59300 KRW — it has decreased by 0.17% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange JWPHARMA(2PB) stocks are traded under the ticker 001067.
001067 stock is 0.17% volatile and has beta coefficient of 0.08. Check out the list of the most volatile stocks — is JWPHARMA(2PB) there?
One year price forecast for JWPHARMA(2PB) has a max estimate of 49000 KRW and a min estimate of 40000 KRW.
Yes, you can track JWPHARMA(2PB) financials in yearly and quarterly reports right on TradingView.
001067 stock has risen by 0.51% compared to the previous week, the month change is a 0.34% rise, over the last year JWPHARMA(2PB) has showed a 4.29% decrease.
001067 net income for the last quarter is 23.69 B KRW, while the quarter before that showed −16.97 B KRW of net income which accounts for 239.56% change. Track more JWPHARMA(2PB) financial stats to get the full picture.
Today JWPHARMA(2PB) has the market capitalization of 695.34 B, it has decreased by 9.23% over the last week.
Yes, 001067 dividends are paid annually. The last dividend per share was 400.00 KRW. As of today, Dividend Yield (TTM)% is 1.32%. Tracking JWPHARMA(2PB) dividends might help you take more informed decisions.
JWPHARMA(2PB) dividend yield was 1.10% in 2023, and payout ratio reached 26.08%. The year before the numbers were 1.98% and 28.17% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 001067 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JWPHARMA(2PB) stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 1.15 K employees. See our rating of the largest employees — is JWPHARMA(2PB) on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JWPHARMA(2PB) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JWPHARMA(2PB) stock shows the sell signal. See more of JWPHARMA(2PB) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on JWPHARMA(2PB) future price: according to them, 001067 price has a max estimate of 49000.00 KRW and a min estimate of 40000.00 KRW. Read a more detailed JWPHARMA(2PB) forecast: see what analysts think of JWPHARMA(2PB) and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JWPHARMA(2PB) EBITDA is 119.21 B KRW, and current EBITDA margin is 15.93%. See more stats in JWPHARMA(2PB) financial statements.